Preview Mode Links will not work in preview mode
  1. All Episodes
  2. Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis

Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis

Oct 3, 2023

Dr. Rae Bacharach discusses the paper, "Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis".

Show references: https://jamanetwork.com/journals/jamaneurology/article-abstract/2806000